Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28640435 | 0.89 | MMP1 (0.33) | — | |
| SCHEMBL25309170 | 0.85 | TRPA1 (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL1071095 | 0.85 | TRPA1 (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL11843148 | 0.84 | POLB (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL19405436 | 0.81 | — | — | |
| SCHEMBL19405399 | 0.81 | — | — | |
| SCHEMBL19405505 | 0.81 | — | — | |
| SCHEMBL1145020 | 0.79 | TRPA1 (0.40) | — | |
| SCHEMBL3656632 | 0.79 | — | — | |
| SCHEMBL136235 | 0.78 | GABRA1 (0.35) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107004906-B | Magnesium-containing electrolyte | 富士胶片和光纯药株式会社 | 2020-04-21 | — | — | CN | disclosed |
| US-10367231-B2 | Magnesium-containing electrolytic solution | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-07-30 | — | — | US | disclosed |
| EP-3226340-B1 | MAGNESIUM-CONTAINING ELECTROLYTIC SOLUTION | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-20170331154-A1 | MAGNESIUM-CONTAINING ELECTROLYTIC SOLUTION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| EP-3226340-A1 | MAGNESIUM-CONTAINING ELECTROLYTIC SOLUTION | Wako Pure Chemical Industries, Ltd. (JP) | 2017-10-04 | — | — | EP | disclosed |
| EP-2838577-A1 | HYDROPHILIC POLYMERIC COATINGS FOR MEDICAL ARTICLES WITH VISUALIZATION MOIETY | SurModics, Inc. (US) | 2015-02-25 | — | — | EP | disclosed |
| US-8956682-B2 | Hydrophilic polymeric coatings for medical articles with visualization moiety | SURMODICS, INC. (US) | 2015-02-17 | — | — | US | disclosed |
| CN-102066498-B | Microcapsules, their production and use | BASF SE | 2013-11-06 | — | — | CN | disclosed |
| WO-2013151991-A1 | HYDROPHILIC POLYMERIC COATINGS FOR MEDICAL ARTICLES WITH VISUALIZATION MOIETY | SURMODICS, INC. (US) | 2013-10-10 | — | — | WO | disclosed |
| US-20130261566-A1 | HYDROPHILIC POLYMERIC COATINGS FOR MEDICAL ARTICLES WITH VISUALIZATION MOIETY | SURMODICS, INC. (US) | 2013-10-03 | — | — | US | disclosed |
| EP-0422535-B1 | Polymerisable perylene-3,4,9,10-tetracarboxylic diimides and polymeric products thereof | BASF AG (DE) | 1994-03-02 | — | — | EP | disclosed |
| EP-0432445-B1 | FLUORESCENT PRINTING INK | BASF Lacke + Farben AG (DE) | 1993-06-02 | — | — | EP | disclosed |
| US-5151516-A | Unsaturated monomers | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-29 | — | — | US | disclosed |
| EP-0227980-B1 | FLUORESCENT AROXYSUBSTITUTED 3,4,9,10-PERYLENETETRACARBOXYLIC ACID-DIIMIDES AND THEIR USE FOR THE CONCENTRATION OF LIGHTS IN SMALL AREAS | BASF Aktiengesellschaft (DE) | 1991-10-09 | — | — | EP | disclosed |
| EP-0432445-A2 | Fluorescent printing ink | BASF Lacke + Farben AG (DE) | 1991-06-19 | — | — | EP | disclosed |
| EP-0422535-A1 | Polymerisable perylene-3,4,9,10-tetracarboxylic diimides and polymeric products thereof | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
| EP-0422474-A2 | Fluorescent pigments | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
| EP-0227980-A2 | Fluorescent aroxysubstituted 3,4,9,10-perylenetetracarboxylic acid-diimides and their use for the concentration of lights in small areas | BASF Aktiengesellschaft (DE) | 1987-07-08 | — | — | EP | disclosed |
| US-4379934-A | Process for two-dimensionally concentrating light, and novel perylene-3,4,9,10-tetracarboxylic acid diimides | BASF AKTIENGESELLSCHAFT (DE) | 1983-04-12 | — | — | US | disclosed |
| EP-0033079-A1 | Perylene-3,4,9,10-tetracarboxylic-acid diimides and their use | BASF Aktiengesellschaft (DE) | 1981-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10367231-B2 | Magnesium-containing electrolytic solution | CA1, CA3, CA2 | TSHR 3749/4885SMN1; SMN2 2311/4885SIGMAR1 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.